AIM
NUVA

Acrospire Investment Management’s NuVasive, Inc. NUVA Stock Holding History

Acrospire Investment Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$15K – 1587
2017
Q2 		$15K Buy
+200
New +$14.9K 0.01% 1673
2016
Q4 		– Sell
-1,100
Closed -$73K – 2469
2016
Q3 		$73K Buy
1,100
+200
+22% +$12.7K 0.05% 792
2016
Q2 		$54K Buy
900
+200
+29% +$10.8K 0.04% 1005
2016
Q1 		$34K Buy
+700
New +$31.8K 0.02% 1243

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Acrospire Investment Management's NUVA Position: Q3 2017 in Review

Acrospire Investment Management sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 200 shares — an estimated $15K sold.

Acrospire Investment Management first reported a position in NUVA in Q1 2016 and held it in 4 quarters. The position peaked at $73K in Q3 2016. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

  • Acrospire Investment Management reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 200 NuVasive, Inc. shares in Q3 2017, an estimated $15K.
  • Acrospire Investment Management first reported a position in NuVasive, Inc. in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's NuVasive, Inc. position peaked at $73K in Q3 2016.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.